US10220063B2 – March 5, 2019 – Compositions and methods for enhancing sexual pleasure and performance

Please complete the required fields.




Inventors :

Dennis M. Jenn

Owner :

ILYSM, LLC

Application Number :

US16056726

Document Number :

US10220063B2

Priority Date :

August 7, 2018

Filing Date :

August 7, 2018

Date of Grant/ Publication :

March 5, 2019

Class :

; A61K36 / 00; A61K36 / 185; A23C15 / 12; A61K31 / 352; A21D2 / 14; A61K9 / 00; A61K31 / 05; A23L29 / 30

Abstract

Pharmaceutical preparations include at least one component that enhances sexual response and at least one other compound that enhances sexual sensitivity and pleasure. The component that enhances sexual response enhances blood flow to the genital region. Examples include compounds that dilate blood vessels, such as compounds that increase the amount of nitric oxide (NO) in the blood. The component that enhances sexual sensitivity and pleasure includes one or more cannabinoid compounds from the plant genus Cannabis , including extracted compounds, synthetic forms, and derivatives thereof. Examples include tetrahydrocannabinol (THC), the main psychoactive constituent of Cannabis , and cannabidiol (CBD), which is less or non-psychoactive and modulates THC activity. The ratio of THC/CBD can be selected depending on age, gender, physical health, and/or psychological condition of the user.

Claim(s)

1. A tablet or capsule for enhancing sexual response and sensitivity in a human, consisting essentially of: a cannabinoid component consisting essentially of about 10 mg to about 500 mg of tetrahydrocannabinol and about 10 mg to about 500 mg of cannabidiol; and a therapeutically effective amount of a sexual response enhancing component selected from the group consisting of sildenafil, tadalafil, and vardenafil.;
13. A tablet or capsule for enhancing sexual response and sensitivity in a human, consisting essentially of: a cannabinoid component consisting essentially of about 10 mg to about 400 mg of tetrahydrocannabinol and about 10 mg to about 400 mg of cannabidiol; and a therapeutically effective amount of a sexual response enhancing component selected from the group consisting of sildenafil, tadalafil, and vardenafil.;
16. A tablet or capsule for enhancing sexual response and sensitivity in a human, consisting essentially of: a cannabinoid component consisting essentially of about 10 mg to about 300 mg of tetrahydrocannabinol and about 10 mg to about 300 mg of cannabidiol; a therapeutically effective amount of a sexual response enhancing component selected from the group consisting of sildenafil, tadalafil, and vardenafil; and at least one supplement selected from the group consisting of L-arginine, yahimbe root, ginseng, gingko biloba , and horny goat weed.;
18. A tablet or capsule for enhancing sexual response and sensitivity in a human, consisting essentially of: a cannabinoid component consisting essentially of about 10 mg to about 250 mg of tetrahydrocannabinol and about 10 mg to about 250 mg of cannabidiol; and a therapeutically effective amount of a sexual response enhancing component selected from the group consisting of sildenafil, tadalafil, and vardenafil.

Summary

No Comments

Leave a comment

Sorry, you must be logged in to post a comment. Login